ImStar Therapeutics Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Private

  • Employees
  • 3

Employees

  • Latest Deal Type
  • Later Stage VC

  • Investors
  • 5

ImStar Therapeutics General Information

Description

Developer of biotechnology-based therapies designed to treat patients with amyotrophic lateral sclerosis disease. The company's therapies are used for the treatment of Alzheimer's, Parkinson's disease and dementia, enabling healthcare providers to cure diseases of their patients efficiently.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Corporate Office
  • 1285 West Broadway
  • Suite 600
  • Vancouver, British Columbia V6H 3X8
  • Canada

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ImStar Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC 29-Oct-2020 00.00 Completed Generating Revenue
3. Seed Round 12-Jun-2016 00.00 00.00 Completed Generating Revenue
2. Seed Round 01-Jan-2014 $2.3M $2.3M Completed Startup
1. Seed Round 01-Sep-2012 Completed Startup
To view ImStar Therapeutics’s complete valuation and funding history, request access »

ImStar Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of biotechnology-based therapies designed to treat patients with amyotrophic lateral sclerosis disease. The co
Biotechnology
Vancouver, Canada
3 As of 2024
00.00
0000000000 0 00.00

000000

derit in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur
0000 000000000
Clarksville, MD
0 As of 0000
00.000
00000000000

000000

t in voluptate velit esse cillum dolore eu fugiat nulla pariatur. Excepteur sint
0000 000000000
Paris, France
00 As of 0000
000.00
00000000000 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

ImStar Therapeutics Competitors (51)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NeuroNascent Venture Capital-Backed Clarksville, MD 0 00.000 00000000000
PulseSight Therapeutics Venture Capital-Backed Paris, France 00 000.00 00000000000 000.00
Herophilus Formerly VC-backed San Francisco, CA 00 000.00 000000&0 000.00
ONL Therapeutics Venture Capital-Backed Ann Arbor, MI 00 000.00 0000000000 0 000.00
Gyroscope Formerly VC-backed London, United Kingdom 00 00000 000000&0 00000
You’re viewing 5 of 51 competitors. Get the full list »

ImStar Therapeutics Patents

ImStar Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11472832-B2 Withanolides useful for the treatment of neurodegenerative diseases Active 25-Nov-2013 0000000000 0
ES-2728870-T3 Witanolides useful for the treatment of neurodegenerative diseases Active 25-Nov-2013 0000000000
CA-2931064-C Withanolides useful for the treatment of neurodegenerative diseases Active 25-Nov-2013 0000000000
CA-2931064-A1 Withanolides useful for the treatment of neurodegenerative diseases Active 25-Nov-2013 0000000000
US-20190315798-A1 Withanolides useful for the treatment of neurodegenerative diseases Active 25-Nov-2013 C07J71/001
To view ImStar Therapeutics’s complete patent history, request access »

ImStar Therapeutics Executive Team (6)

Name Title Board Seat
Agnes Chan Ph.D Chief Operating Officer
You’re viewing 1 of 6 executive team members. Get the full list »

ImStar Therapeutics Board Members (7)

Name Representing Role Since
Elizabeth Douville Ph.D AmorChem Board Member 000 0000
You’re viewing 1 of 7 board members. Get the full list »

ImStar Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

ImStar Therapeutics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds
AmorChem Venture Capital Minority 000 0000 000000 0
Accel-Rx Accelerator/Incubator Minority 000 0000 000000 0
AviTx Corporation Minority 000 0000 000000 0
BDC Capital Growth/Expansion Minority 000 0000 000000 0
eFund (Angel investing) Angel Group Minority 000 0000 000000 0
To view ImStar Therapeutics’s complete investors history, request access »

ImStar Therapeutics FAQs

  • When was ImStar Therapeutics founded?

    ImStar Therapeutics was founded in 2012.

  • Who is the founder of ImStar Therapeutics?

    Jean-Pierre Julien Ph.D, Daniel Wattier, and Jennifer Kaufman-Shaw Ph.D are the founders of ImStar Therapeutics.

  • Where is ImStar Therapeutics headquartered?

    ImStar Therapeutics is headquartered in Vancouver, Canada.

  • What is the size of ImStar Therapeutics?

    ImStar Therapeutics has 3 total employees.

  • What industry is ImStar Therapeutics in?

    ImStar Therapeutics’s primary industry is Biotechnology.

  • Is ImStar Therapeutics a private or public company?

    ImStar Therapeutics is a Private company.

  • What is ImStar Therapeutics’s current revenue?

    The current revenue for ImStar Therapeutics is 000000.

  • How much funding has ImStar Therapeutics raised over time?

    ImStar Therapeutics has raised $4.1M.

  • Who are ImStar Therapeutics’s investors?

    AmorChem, Accel-Rx, AviTx, BDC Capital, and eFund (Angel investing) have invested in ImStar Therapeutics.

  • Who are ImStar Therapeutics’s competitors?

    NeuroNascent, PulseSight Therapeutics, Herophilus, ONL Therapeutics, and Gyroscope are some of the 51 competitors of ImStar Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »